Literature DB >> 17407195

CD4-mediated functional activation of human CD4+CD25+ regulatory T cells.

Christian Becker1, Jan Kubach, John Wijdenes, Jürgen Knop, Helmut Jonuleit.   

Abstract

Naturally occurring CD4(+)CD25(+)FoxP3(+) regulatory T cells (CD25(+) Tregs) constitute a specialized population of T cells that is essential for the maintenance of peripheral self-tolerance. The immune regulatory function of CD25(+) Tregs depends upon their activation. We found that anti-CD4 antibodies activate the suppressive function of human CD25(+) Tregs in a dose-dependent manner. We demonstrate that CD4-activated CD25(+) Tregs suppress the proliferation of CD4(+) and CD8(+) T cells, their IL-2 and IFN-gamma production as well as the capacity of CD8(+) T cells to re-express CD25. By contrast, anti-CD4 stimulation did not induce suppressive activity in conventional CD4(+) T cells. These results identify CD4 as a trigger for the suppressive function of CD25(+) Tregs and suggest a possible CD4-mediated exploitation of these cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17407195     DOI: 10.1002/eji.200636480

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Regulatory T cells and regulation of allergic airway disease.

Authors:  Helen Martin; Christian Taube
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

Review 2.  The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention.

Authors:  Joanna Domagala-Kulawik
Journal:  Transl Lung Cancer Res       Date:  2015-04

3.  Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human.

Authors:  Fabian Birzele; Tanja Fauti; Heiko Stahl; Martin C Lenter; Eric Simon; Dagmar Knebel; Andreas Weith; Tobias Hildebrandt; Detlev Mennerich
Journal:  Nucleic Acids Res       Date:  2011-07-04       Impact factor: 16.971

4.  Boosting regulatory T cell function by CD4 stimulation enters the clinic.

Authors:  Christian Becker; Tobias Bopp; Helmut Jonuleit
Journal:  Front Immunol       Date:  2012-06-18       Impact factor: 7.561

5.  Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells.

Authors:  Bettina Trinschek; Felix Luessi; Catharina C Gross; Heinz Wiendl; Helmut Jonuleit
Journal:  Int J Mol Sci       Date:  2015-07-17       Impact factor: 5.923

6.  Virus infection drives IL-2 antibody complexes into pro-inflammatory agonists in mice.

Authors:  Wendy W L Lee; Teck-Hui Teo; Fok-Moon Lum; Anand K Andiappan; Siti Naqiah Amrun; Laurent Rénia; Olaf Rötzschke; Lisa F P Ng
Journal:  Sci Rep       Date:  2016-11-25       Impact factor: 4.379

7.  miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression.

Authors:  Heiko F Stahl; Tanja Fauti; Nina Ullrich; Tobias Bopp; Jan Kubach; Werner Rust; Paul Labhart; Vassili Alexiadis; Christian Becker; Mathias Hafner; Andreas Weith; Martin C Lenter; Helmut Jonuleit; Edgar Schmitt; Detlev Mennerich
Journal:  PLoS One       Date:  2009-09-24       Impact factor: 3.240

Review 8.  Induction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate Immunity.

Authors:  Gabriel N Kaufman; Amir H Massoud; Marieme Dembele; Madelaine Yona; Ciriaco A Piccirillo; Bruce D Mazer
Journal:  Front Immunol       Date:  2015-09-11       Impact factor: 7.561

9.  Antibody induced CD4 down-modulation of T cells is site-specifically mediated by CD64(+) cells.

Authors:  Stephanie Vogel; Elena Grabski; Daniela Buschjäger; Frank Klawonn; Marius Döring; Junxi Wang; Erika Fletcher; Ingo Bechmann; Torsten Witte; Martin Durisin; Burkhart Schraven; Sara M Mangsbo; Kurt Schönfeld; Niklas Czeloth; Ulrich Kalinke
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

Review 10.  Tregalizumab - A Monoclonal Antibody to Target Regulatory T Cells.

Authors:  Martin König; Faiza Rharbaoui; Silke Aigner; Benjamin Dälken; Jörg Schüttrumpf
Journal:  Front Immunol       Date:  2016-01-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.